192 related articles for article (PubMed ID: 15383203)
21. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
22. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
23. PET/CT today and tomorrow in veterinary cancer diagnosis and monitoring: fundamentals, early results and future perspectives.
Lawrence J; Rohren E; Provenzale J
Vet Comp Oncol; 2010 Sep; 8(3):163-87. PubMed ID: 20691025
[TBL] [Abstract][Full Text] [Related]
24. PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D; Martin WH
Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
[TBL] [Abstract][Full Text] [Related]
25. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
26. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
[TBL] [Abstract][Full Text] [Related]
27. PET and PET/CT in radiotherapy.
Könemann S; Weckesser M
Recent Results Cancer Res; 2008; 170():243-53. PubMed ID: 18019631
[No Abstract] [Full Text] [Related]
28. PET/CT in radiation oncology.
Fonti R; Conson M; Del Vecchio S
Semin Oncol; 2019 Jun; 46(3):202-209. PubMed ID: 31378377
[TBL] [Abstract][Full Text] [Related]
29. PET and PET-CT. State of the art and future prospects.
Fanti S; Franchi R; Battista G; Monetti N; Canini R
Radiol Med; 2005; 110(1-2):1-15. PubMed ID: 16163136
[TBL] [Abstract][Full Text] [Related]
30. PET/CT today and tomorrow.
Townsend DW; Carney JP; Yap JT; Hall NC
J Nucl Med; 2004 Jan; 45 Suppl 1():4S-14S. PubMed ID: 14736831
[TBL] [Abstract][Full Text] [Related]
31. Dual-modality PET/CT instrumentation-today and tomorrow.
Lonsdale MN; Beyer T
Eur J Radiol; 2010 Mar; 73(3):452-60. PubMed ID: 20096520
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
[TBL] [Abstract][Full Text] [Related]
33. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Endo K; Oriuchi N; Higuchi T; Iida Y; Hanaoka H; Miyakubo M; Ishikita T; Koyama K
Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302
[TBL] [Abstract][Full Text] [Related]
34. Clinical experience with the first combined positron emission tomography/computed tomography scanner in Australia.
Lau WF; Binns DS; Ware RE; Ramdave S; Cachin F; Pitman AG; Hicks RJ
Med J Aust; 2005 Feb; 182(4):172-6. PubMed ID: 15720173
[TBL] [Abstract][Full Text] [Related]
35. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
36. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
37. PET/CT in radiation oncology.
Pan T; Mawlawi O
Med Phys; 2008 Nov; 35(11):4955-66. PubMed ID: 19070229
[TBL] [Abstract][Full Text] [Related]
38. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
39. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.
Weber WA; Grosu AL; Czernin J
Nat Clin Pract Oncol; 2008 Mar; 5(3):160-70. PubMed ID: 18253106
[TBL] [Abstract][Full Text] [Related]
40. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System.
Nakamoto R; Nakamoto Y; Ishimori T; Fushimi Y; Kido A; Togashi K
J Nucl Med; 2018 May; 59(5):846-851. PubMed ID: 29097407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
